1)Okada Y, Wu D, Trynka G, et al:Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376-381,2014
2)Holers VM, Demoruelle MK, Kuhn KA, et al:Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol 14:542-557,2018
3)Maeda Y, Kurakawa T, Umemoto E, et al:Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis Rheumatol 68:2646-2661,2016
4)Scher JU, Sczesnak A, Longman RS, et al:Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202,2013
5)Zhang X, Zhang D, Jia H, et al:The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21:895-905,2015
6)Kishikawa T, Maeda Y, Nii T, et al:Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann Rheum Dis 79:103-111,2020
7)Tomofuji Y, Maeda Y, Oguro-Igashira E, et al:Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese. Ann Rheum Dis 80:1575-1583,2021
8)Emmi G, Bettiol A, Niccolai E, et al:Butyrate-Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome. Circ Res 128:278-280,2021
9)Alpizar-Rodriguez D, Lesker TR, Gronow A, et al:Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis 78:590-593,2019
10)Ivanov II, Atarashi K, Manel N, et al:Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498,2009
11)Consolandi C, Turroni S, Emmi G, et al:Behçet's syndrome patients exhibit specific microbiome signature. Autoimmun Rev 14:269-276,2015
12)Kinumaki A, Sekizuka T, Hamada H, et al:Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis. Front Microbiol 6:824,2015
13)Wang X, Zhang L, Wang Y, et al:Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children. Int Immunopharmacol 58:1-8,2018
14)Yu M, Li L, Ren Q, et al:Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition. Front Pharmacol 13:783679,2022
15)Noval Rivas M, Wakita D, Franklin MK, et al:Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation. Immunity 51:508-521,2019
16)Singh JA, Saag KG, Bridges SL Jr, et al:2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 68:1-26,2016
17)Smolen JS, Emery P, Fleischmann R, et al:Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet 383:321-332,2014
18)Zaharko DS, Bruckner H, Oliverio VT:Antibiotics alter methotrexate metabolism and excretion. Science 166:887-888,1969
19)Nayak RR, Alexander M, Deshpande I, et al:Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host Microbe 29:362-377,2021
20)Peppercorn MA, Goldman P:The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther 181:555-562,1972